← 產業報告目錄
Personalized Psychiatry Market Size, Share & Trends Analysis Report, By Type (Products, Services, Software), By Therapeutic Areas (Depression, Anxiety, Bipolar Disorder, Schizophrenia, Addiction, Others), By Region, Forecasts, 2024-2031
出版商 InsightAce Analytic產業別 Healthcare & Life Sciences出版日期 2026-02-12頁數 180報告編號 INSIGHTACE-b093739340
授權報價
| Single User PDF | $4,500 USD |
| Global Site License PDF | $9,500 USD |
報告摘要
With a 2023 valuation of USD 4.2 Bn, the global Personalized Psychiatry Market is set to increase to USD 10.1 Bn by 2031, demonstrating a CAGR of 11.8% during the 2024–2031 forecast window.
The Personalized Psychiatry sector involves a method of treating mental health issues that takes into account the unique qualities of each patient. This domain has witnessed considerable transformation owing to technological breakthroughs and shifting healthcare dynamics.
Several factors contribute to this trajectory, including heightened appetite for next-generation products, expanding applications across diverse end-use sectors, and supportive government initiatives.
The market landscape is structured across several key segments—spanning type, application, distribution channel, and region—each contributing uniquely to overall market expansion.
Geographically, North America maintains a leading position owing to advanced infrastructure, high R&D expenditure, and a well-established regulatory environment. Meanwhile, Asia-Pacific is emerging as the fastest-growing region, supported by rapid industrialization and expanding end-user bases.
Industry participants are deploying a range of strategies—including partnerships, mergers, technological investments, and portfolio diversification—to consolidate their market standing.
This comprehensive research study delivers granular insights into market sizing, trend analysis, competitive benchmarking, and forward-looking projections to support strategic decision-making for industry participants and investors.
目錄 Table of Contents
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Personalized Psychiatry Market Snapshot
Chapter 4. Global Personalized Psychiatry Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter's Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: by Type Estimates & Trend Analysis
5.1. by Type & Market Share, 2019 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Type:
5.2.1. Products
5.2.1.1. Diagnostics
5.2.1.2. Therapeutics
5.2.2. Services, Software
Chapter 6. Market Segmentation 2: by Therapeutic Areas Estimates & Trend Analysis
6.1. by Therapeutic Areas & Market Share, 2019 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Therapeutic Areas:
6.2.1. Depression
6.2.2. Anxiety
6.2.3. Bipolar Disorder
6.2.4. Schizophrenia
6.2.5. Addiction
6.2.6. Others
Chapter 7. Personalized Psychiatry Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
7.1.2. North America Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2023-2031
7.1.3. North America Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.2. Europe
7.2.1. Europe Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
7.2.2. Europe Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2023-2031
7.2.3. Europe Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.3. Asia Pacific
7.3.1. Asia Pacific Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
7.3.2. Asia Pacific Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2023-2031
7.3.3. Asia Pacific Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.4. Latin America
7.4.1. Latin America Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
7.4.2. Latin America Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2023-2031
7.4.3. Latin America Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
7.5. Middle East & Africa
7.5.1. Middle East & Africa Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by Type, 2023-2031
7.5.2. Middle East & Africa Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by Therapeutic Areas, 2023-2031
7.5.3. Middle East & Africa Personalized Psychiatry Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. GreyBird Ventures
8.2.2. Sunovion Pharmaceuticals Inc.
8.2.3. HBNC Holding GmbH
8.2.4. Arcara Personalized Psychiatry
8.2.5. Starling Minds
8.2.6. Karuna Therapeutics
8.2.7. CBT Plus
8.2.8. AltheaDx, Inc.
8.2.9. WayForward
8.2.10. BrightQuest
8.2.11. Peak Mental Wellness
量子訊息有限公司為 InsightAce Analytic 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們